HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

6- phosphonylmethoxyethoxy- 2,4- diaminopyrimidine

structure in first source

Also Known As:

PMEO-DAPym

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - 6-phosphonylmethoxyethoxy-2,4-diaminopyrimidine: 2
Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - 6-phosphonylmethoxyethoxy-2,4-diaminopyrimidine: 2

Experts

1.	Andrei, Graciela: 1 article (01/2013)
2.	Balestra, Emanuela: 1 article (01/2013)
3.	Balzarini, Jan: 1 article (01/2013)
4.	Holý, Antonín: 1 article (01/2013)
5.	Huskens, Dana: 1 article (01/2013)
6.	Introini, Andrea: 1 article (01/2013)
7.	Liekens, Sandra: 1 article (01/2013)
8.	Margolis, Leonid: 1 article (01/2013)
9.	Perno, Carlo-Federico: 1 article (01/2013)
10.	Schols, Dominique: 1 article (01/2013)

Related Diseases

1.	HIV Infections (HIV Infection) 01/01/2013 - "PMEO-DAPym belongs conceptually to a new class of efficient multitargeted antivirals for concomitant dual-viral (HSV/HIV) infection therapy through inhibition of virus-specific pathways (i.e. "
2.	Neoplasms (Cancer) 10/01/2004 - "Several PMEO-DAPym derivatives proved as potent as PMEA (adefovir) and (R)-PMPA (tenofovir) in inhibiting Moloney murine sarcoma virus (MSV)-induced tumor formation in newborn NMRI mice. "

Related Drugs and Biologics

1.	Antiviral Agents (Antivirals)
2.	Tenofovir (Viread)
3.	adefovir

Related Therapies and Procedures

1.	Therapeutics